‘Contaminated' supermarket item is linked to mystery hepatitis outbreak that left 95 Brits ill and 58 hospitalised
OFFICIALS are investigating a mysterious surge in hepatitis A cases believed to be linked to a supermarket item.
A total of 95 people have been left ill from the outbreak with a further 58 falling so ill they needed to be hospitalised.
3
3
The UK Health Security Agency (UKHSA) has confirmed two separate clusters of the virus have been identified.
Officials have received reports of 54 cases since December 2024 and are now investigating the cause of the outbreak.
Patient interviews have indicated that the outbreak comes from a specific food item purchased from an unnamed supermarket.
A UKHSA report reads: "A particular food item purchased from a particular supermarket has emerged as a possible vehicle of transmission due to its frequent reported consumption."
The product has not been named despite officials identifying it as a "possible vehicle of transmission."
The first identified cluster saw 19 people hospitalised with the infection that affects the liver.
Most of the patients in the first cluster to be identified were between the ages of 50 and 69.
The second cluster saw a further 39 people requiring hospitalisation after catching the virus.
Cases related to the first cluster were identified between January 2021 and March 2025.
The latest wave of infections began in January 2023 with cases still being reported in March this year.
No deaths linked to the outbreak have been reported as of yet.
Public Health Scotland are leading the investigation alongside the UKHSA.
Hepatitis A begins with mild symptoms but can quickly develop into a more serious illness.
It causes weakness and fatigue, a loss of appetite, nausea, vomiting and diarrhoea, fever jaundice and abdominal pain.
If left untreated the infection can lead to liver failure and can even be fatal.
3
Unlike hepatitis B and C, hepatitis A isn't known to cause chronic liver disease.
Symptoms tend to develop within two months of infection but can go undetected for longer.
The NHS warns that children and some adults may have no symptoms.
In less extreme cases the virus usually clears up on its own within six months but doctors can prescribe medication to alleviate symptoms.
The UKHSA is continuing to investigate the recent outbreaks with an unnamed food item from an unnamed supermarket identified as a possible cause.
UKHSA officials have not stated the name of supermarket, or the food item.
The UKHSA report reads: "Given the reported lack of international travel in most cases, and implicated food items, further investigations into the possible sources of these clusters are in progress to inform control measures."
The UKHSA has been contacted for comment.
The symptoms of hepatitis A you need to be aware of
Symptoms of Hepatitis A can include jaundice, a yellowing of the skin and whites of the eyes, dark-coloured urine and itchy skin.
This is because when your liver isn't working properly, it stops being able to get rid of bilirubin, a substance that causes jaundice.
There may be earlier flu-like symptoms including mild fever, joint and muscle pain, feeling and being sick, diarrhoea and stomach pain.
Losing your appetite, feeling or being sick and pain in the upper right part of your tummy could also be a sign of the condition.
Not everyone infected will have all these symptoms.
Anyone with suspected hepatitis A infection should contact their GP and remain at home, until their GP advises their return to school or the workplace.
It is an unpleasant illness but is not usually serious and most people make a full recovery in two months.
However, it can last several months and also be deadly if it causes liver failure — when the organ stops working properly.
More information on hepatitis A can be found on the NHS website.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
an hour ago
- Times
What can a £5,000 at-home laser do?
With the beauty-gadget industry growing at four times the rate of the overall skincare category, with sales projected to hit $92.55 billion by 2028, it seems to be becoming the favoured option for people who want the results of a visit to the aesthetician, but prefer less invasive approaches. • This article contains affiliate links that can earn us revenue As a result the British wellness brand LYMA is doing better than ever. Founded in 2018, its initial offering was the LYMA supplement, a gold-coloured capsule containing active ingredients formulated to be bioavailable and therefore fully absorbed by the body. Despite coming at a price — around £199 for a month's supply — the pills frequently sold out and were nicknamed the 'supermodel supplement' to those in the wellness world. Unsurprisingly, LYMA loyalists were thrilled when LYMA dropped its first at-home clinic-grade laser in 2020, the launch helped LYMA receive a 40 per cent increase in turnover to £32.5 million, with US sales accounting for 70 per cent of their total revenues. Now the range includes both the original LYMA laser as well as the LYMA Laser Pro which launched in March 2024. Both use technology called low-level laser therapy (LLLT) first developed in the 1960s which was previously used to treat medical injuries such as healing tendons and rebuilding cartilage. The founder of LYMA, Lucy Goff, decided to harness this existing technology and re-engineer it for the cosmetic market, creating a portable, cordless device that could be used at home without the supervision of a doctor or a prescription*. Goff consulted geneticists, longevity scientists and surgeons and spent five years developing the laser. In contrast to some other cosmetic procedures which have to deliver micro-injury to the skin and inflict damage in order to create collagen, the LYMA lasers utilise powerful, zero-damage cold laser technology. The original iteration is a smaller, handbag-sized device that features a patented 8cm² treatment lens, primarily designed for the face. The LYMA Laser Pro can also be used on the neck and body, and has cut down the initial treatment time of 15 minutes per day to just three minutes per area of concern (such as cheeks, forehead and eye areas), or a full face in as little as 9 minutes, thanks to its larger 30cm² lens. Dr Graeme Glass, a craniofacial, aesthetic and plastic surgeon and now the director of aesthetics at LYMA, helped develop the laser and has written several medical papers on its technology. With many women losing fat through the rise of Ozempic and other weight loss alternatives, Glass recommends the LYMA laser. 'Losing weight can be associated with the loss of subcutaneous fat which can give the appearance of laxity as the face and neck structures hang on relatively loose ligaments,' he says. 'The skin loses its lustre because of loss of water content in the dermis, lack of synthesis of the protective fatty acids that condition the skin, and lack of vitamins and minerals essential for healthy skin function.' Just like the rest of our body, our skin needs energy function, which usually comes in the form of ATP (adenosine triphosphate) to help the skin stay hydrated, produce collagen and elastic, as well as promote cell renewal. Without enough ATP, the skin becomes dull and will start to sag or age at a faster rate, Glass explains. To counteract this, the LYMA laser uses the technique of low level laser therapy using near-infrared light. According to LYMA's website: 'this light triggers a natural process in your cells called photobiomodulation, which helps your skin produce ATP more efficiently. It's like charging up the skin's internal battery, so it has the energy it needs to repair and regenerate itself.' LYMA claims that over time the ATP produced through using the laser will help boost collagen and elastin production — both key for the appearance of firmer, smoother skin. The brand promises an improvement in as little as 30 days with daily use and recommends following with twice weekly sessions as maintenance. LYMA's own clinical trials involving 10 subjects showed 64.3 per cent improvement in pigmentation, a 53.8 percent improvement in wrinkles, a 42 per cent improvement in rosacea symptoms, and a 56 per cent decline in acne and blemishes.** At around £1,999 and around £4,995 respectively, the LYMA lasers are undoubtedly an expensive piece of kit, but that hasn't kept customers away. LYMA sold 47 per cent more stock than predicted in the first 24 hours of its US launch and counts a whole host of celebrities, including Sienna Miller and Gwyneth Paltrow, as loyal users. Likewise, the launch of LYMA skincare, a duo of anti-ageing serum and creams, had a waitlist of around 30,000 expectant customers. But it's the Laser Pro which is helping the brand put a stake in the ground of the $211 billion global professional beauty services market — and a pretty big stake at that. * LYMA's policy outlines if you have a recurring or previously diagnosed health condition that concerns you, or are taking prescription medication, upon purchase of our products you agree to seek medical advice from your GP before taking our products and/or making dietary and lifestyle changes. **Based on an independent clinical trial measured by Cutometer dual MPA 580 — a device used to measure skin elasticity and firmness by assessing the skin's ability to deform and return to its original shape, plus LYMA's own studies which can be found here.
The Independent
2 hours ago
- The Independent
Families of Nottingham attack victims to hold memorial walk two years on
The families of the Nottingham attack victims will hold a memorial walk to remember their loved ones two years after their deaths. The relatives of 19-year-old students Grace O'Malley-Kumar and Barnaby Webber and 65-year-old caretaker Ian Coates will meet at St Paul's Church in Lenton Road at 11.30am on Friday before walking to the two locations of the attacks. They say this is 'to show respect for the horror that their loved ones endured at the hands of this monster', to 'wish them peace for wherever they may now be' and 'mark the importance of their fight for justice'. Mr Webber's mother Emma Webber said: 'We will lay flowers, with our love and memories of three wonderful human beings.' The walk, which is set to last 90 minutes, is open to the public and participants will wear green and gold for the University of Nottingham, where Ms O'Malley-Kumar and Mr Webber were studying, and red for Mr Coates's beloved Nottingham Forest. Valdo Calocane, who had been diagnosed with paranoid schizophrenia, killed them and attempted to kill three more people in Nottingham on June 13 2023. He was sentenced to an indefinite hospital order in January 2024 after admitting manslaughter by diminished responsibility and attempted murder. A February report into the care received by Calocane said he was not forced to have long-lasting antipsychotic medication because he did not like needles, and other patients at Nottinghamshire Healthcare NHS Foundation Trust also went on to commit 'extremely serious' acts of violence. Prosecutors, police and medical professionals will be scrutinised in a two-year inquiry, including the Independent Office for Police Conduct (IOPC). Sharon Miller and Wayne Birkett, survivors of the attacks, said in a statement that a 'collective, united effort' is needed to improve the effectiveness of local public services and prevent future tragedies. Their statement read: 'On this two-year anniversary, we remember those we lost and look to the future with hope – hope that lessons will be learned and meaningful change and action will follow. 'We are grateful to the bereaved families for inviting us to the memorial walk they have so thoughtfully arranged.'
The Independent
2 hours ago
- The Independent
MPs to discuss ban on assisted dying adverts as Bill returns to Parliament
A ban on advertising assisted dying is to be debated as the controversial Bill returns to Parliament. The regulation of substances to be used by a terminally ill person to bring about their death is also due to be discussed by MPs in the Commons on Friday. The Terminally Ill Adults (End of Life) Bill is undergoing a second day of report stage, with various amendments likely to be debated and possibly voted on. Its third reading – where a vote is taken on the overall Bill – could take place next Friday. The Bill passed second reading stage by a majority of 55 during a historic vote in November, which saw MPs support the principle of assisted dying. Various reports have indicated some MPs who voted in favour last year could withdraw their support amid concerns around safeguards and how much scrutiny the proposed legislation has received, while others might switch to supporting a Bill that backers argue has been strengthened over time. Opinion in the medical community has been divided, with the Royal College of Physicians (RCP) and Royal College of Psychiatrists (RCPsych) expressing concern, but some MPs who are doctors are among the Bill's strongest supporters. Seven RCPsych members, including a former president and vice president, have written to MPs to distance themselves from their college's concern, instead describing the current Bill as 'workable, safe and compassionate' with a 'clear and transparent legal framework'. Meanwhile, the Children's Commissioner for England has repeated her call for children's voices to be heard in the conversation. Dame Rachel de Souza said: 'Children's views have at best been side-lined, at worst written off entirely simply because they would not fall within the scope of the current scope of legislation. 'They have spoken passionately about their worries that this Bill could be extended further. We need only to look to other models, such as Canada, where proposals for assisted death to be expanded to 'mature minors' – children – are a live issue, to understand the source of their concern. 'This Bill has raised the level of debate on important and challenging subjects in England – but children have raised very real concerns with me about their opportunity to shape this legislation, which could impact them as they reach adulthood, or impact them in indirect ways through the deaths of loved ones.' Demonstrators are once again expected to gather outside Parliament to make their views known on the Bill. Disability campaigner George Fielding, representing campaign group Not Dead Yet UK, argued the Bill 'risks state-sanctioned suicide'. He added: 'It risks making people feel like a burden while ignoring the social, economic and systemic pressures that deny people the treatment and dignity they need to live. 'This is not choice. This is coercion, masquerading as compassion.' But Claire Macdonald, director of My Death, My Decision, which is in favour of assisted dying, said the public mood is clear that change is needed. She said: 'We hope MPs strike the careful balance between creating a law that is strong and safe, with a system that works for dying people, giving them choice and compassion at the end of life. 'What is clear is that no-one should be forced to suffer, and the British public wants politicians to change the law on assisted dying.' In a letter to MPs this week, Labour's Kim Leadbeater, the parliamentarian behind the Bill, said supporters and opponents appear in agreement that 'if we are to pass this legislation it should be the best and safest Bill possible'. She added: 'I'm confident it can and will be.' Among the amendments to the Bill expected to be discussed on Friday are a ban on advertising an assisted dying service were the law to change, with Ms Leadbeater previously saying it 'would feel inappropriate for this to be something which was advertised'. But Bill opponent Labour MP Paul Waugh warned of 'unspecified exceptions, which could make the ban itself worthless', adding that he had put forward a tighter amendment to 'strengthen the Bill on this issue and to better protect the vulnerable'. Ms Leadbeater said other possible amendments include ensuring 'any approved substance used for assisted dying is subject to robust regulation and scrutiny', which she said is 'essential for clinical safety, public confidence and ethical integrity'. Earlier this week, a group of charities wrote to MPs to express 'serious concerns' about what they described as an 'anorexia loophole', arguing people with eating disorders could end up qualifying for assisted dying because of the physical consequences of their illness. However, an amendment preventing a person meeting the requirements for an assisted death 'solely as a result of voluntarily stopping eating or drinking' – tabled by Labour's Naz Shah – was accepted by Ms Leadbeater without a vote last month. Ms Leadbeater said this, combined with existing safeguards in the Bill, would rule out people with anorexia falling into its scope. As it stands, the proposed legislation would allow terminally ill adults in England and Wales, with fewer than six months to live, to apply for an assisted death, subject to approval by two doctors and a panel featuring a social worker, senior legal figure and psychiatrist. MPs are entitled to have a free vote on the Bill and any amendments, meaning they vote according to their conscience rather than along party lines.
